Financial Statements

Acorda Therapeutics Inc

Acorda Therapeutics Inc (ACOR)

$7.22
-0.82 (-10.20%)
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in millions

Retained Earning Schedule

Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Retained Earnings (Previous Year) -394-455-244-209-220-238-255-409-440-
Net Income -27334-223-3511181615531-12
Stock Dividends -2812-----0-428
Dividend Paid ----------
Retained Earnings -667-394-455-244-209-220-238-255-409-440

PPE Schedule

Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Gross PPE 6137344046171743-
Annual Depreciation 196581726815131426613
Capital Expenditure -90-34-14-274-7-484-15-14-6-9
Net PPE 1666137344046171743

Intangible and Goodwill Schedule

Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Intangible and Goodwill (Previous Year) -2199176166141,023717711
New Purchases -311-267-322-221-580-435-40--249-227
Intangible and Goodwill 2199176166141,023717711402

Acorda Therapeutics Inc income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Acorda Therapeutics Inc FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.